These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 39406906)

  • 1. Liver Macrophage Diversity in Health and Disease.
    Horn P; Tacke F
    Results Probl Cell Differ; 2024; 74():175-209. PubMed ID: 39406906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting hepatic macrophages to treat liver diseases.
    Tacke F
    J Hepatol; 2017 Jun; 66(6):1300-1312. PubMed ID: 28267621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Macrophages as key regulators of liver health and disease.
    Papachristoforou E; Ramachandran P
    Int Rev Cell Mol Biol; 2022; 368():143-212. PubMed ID: 35636927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic plasticity of macrophage functions in diseased liver.
    Ritz T; Krenkel O; Tacke F
    Cell Immunol; 2018 Aug; 330():175-182. PubMed ID: 29454647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.
    van der Heide D; Weiskirchen R; Bansal R
    Front Immunol; 2019; 10():2852. PubMed ID: 31849997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities.
    Wen Y; Lambrecht J; Ju C; Tacke F
    Cell Mol Immunol; 2021 Jan; 18(1):45-56. PubMed ID: 33041338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage Phenotype and Function in Liver Disorder.
    Dou L; Shi X; He X; Gao Y
    Front Immunol; 2019; 10():3112. PubMed ID: 32047496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver Injury and the Macrophage Issue: Molecular and Mechanistic Facts and Their Clinical Relevance.
    Roohani S; Tacke F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Notch signaling regulates macrophage-mediated inflammation in metabolic dysfunction-associated steatotic liver disease.
    Guo W; Li Z; Anagnostopoulos G; Kong WT; Zhang S; Chakarov S; Shin A; Qian J; Zhu Y; Bai W; Cexus O; Nie B; Wang J; Hu X; Blériot C; Liu Z; Shen B; Venteclef N; Su B; Ginhoux F
    Immunity; 2024 Oct; 57(10):2310-2327.e6. PubMed ID: 39317200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloid-specific IRE1alpha deletion reduces tumour development in a diabetic, non-alcoholic steatohepatitis-induced hepatocellular carcinoma mouse model.
    Van Campenhout S; Tilleman L; Lefere S; Vandierendonck A; Raevens S; Verhelst X; Geerts A; Van Nieuwerburgh F; Van Vlierberghe H; Devisscher L
    Metabolism; 2020 Jun; 107():154220. PubMed ID: 32243868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease - novel insights into cellular communication circuits.
    Peiseler M; Schwabe R; Hampe J; Kubes P; Heikenwälder M; Tacke F
    J Hepatol; 2022 Oct; 77(4):1136-1160. PubMed ID: 35750137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding Macrophage Complexity in Metabolic Dysfunction-Associated Steatotic Liver Disease: Transitioning from the M1/M2 Paradigm to Spatial Dynamics.
    Ahamed F; Eppler N; Jones E; Zhang Y
    Livers; 2024 Sep; 4(3):455-478. PubMed ID: 39328386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis.
    Vonderlin J; Chavakis T; Sieweke M; Tacke F
    Cell Mol Gastroenterol Hepatol; 2023; 15(6):1311-1324. PubMed ID: 36907380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages in the Aging Liver and Age-Related Liver Disease.
    Stahl EC; Haschak MJ; Popovic B; Brown BN
    Front Immunol; 2018; 9():2795. PubMed ID: 30555477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver macrophages in healthy and diseased liver.
    Abdullah Z; Knolle PA
    Pflugers Arch; 2017 Apr; 469(3-4):553-560. PubMed ID: 28293730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver macrophages revisited: The expanding universe of versatile responses in a spatiotemporal context.
    Guillot A; Tacke F
    Hepatol Commun; 2024 Jul; 8(7):. PubMed ID: 38967563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP activation in liver macrophages via depletion of MST1/MST2 enhances liver inflammation and fibrosis in MASLD.
    Zhang J; Chen W; Song K; Song K; Kolls J; Wu T
    FASEB J; 2024 Sep; 38(17):e70026. PubMed ID: 39215627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kupffer-cell depletion in chronic liver disease: implications for hepatic carcinogenesis.
    Manifold IH; Triger DR; Underwood JC
    Lancet; 1983 Aug; 2(8347):431-3. PubMed ID: 6135915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of hepatic macrophages in liver metastasis.
    Keirsse J; Van Damme H; Geeraerts X; Beschin A; Raes G; Van Ginderachter JA
    Cell Immunol; 2018 Aug; 330():202-215. PubMed ID: 29661474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.